DISEASE INDICATIONS: Thromboembolism

MANUFACTURER: Alexion Pharmaceuticals

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Andexxa is a medication used to reverse anticoagulant effects caused by apixaban and rivaroxaban in patients suffering from uncontrolled, life-threatening bleeding.